Trials / Completed
CompletedNCT00757978
Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms
Phase 4 Memantine as Adjunctive Therapy for Schizophrenia Negative Symptoms in Patients Using Clozapine. A Randomized, Double-Blind, Placebo Controled Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Hospital de Clinicas de Porto Alegre · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Memantine as an add-on therapy to clozapine may improve schizophrenia negative symptoms and cognitive functioning.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | memantine | memantine 10mg twice a day |
| DRUG | placebo | 1 capsule of placebo twice a day |
Timeline
- Start date
- 2006-01-01
- Primary completion
- 2008-01-01
- Completion
- 2008-03-01
- First posted
- 2008-09-23
- Last updated
- 2008-12-18
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT00757978. Inclusion in this directory is not an endorsement.